Analytical Data
-
基因名
CCDC41
- Application
-
别名
Coiled-coil domain-containing protein 41Renal carcinoma antigen NY-REN-58
-
种属
Human
-
表达系统
E. coli
-
标签
N- His-SUMO
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9Y592
-
表达区间
1-568aa
-
分子量
83.4 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CCDC41 (Coiled-Coil Domain Containing 41) is a protein that has gained increasing attention in recent years due to its potential role in cellular processes and disease mechanisms. Initial studies suggested that CCDC41 is involved in cellular responses to stress, particularly in relation to DNA damage repair and maintenance of genomic stability. Its coiled-coil domain indicates a structural element that may facilitate protein-protein interactions, hinting at a possible role in organizing intracellular signaling complexes. Investigations have indicated that mutations or dysregulation of CCDC41 expression may link it to various pathologies, including cancer and neurodegenerative disorders. Understanding the structure-function relationship of CCDC41, as well as its molecular interactions, could provide valuable insights into its biological functions and potential therapeutic targets. Moreover, the recombinant expression of CCDC41 provides an opportunity to analyze its functional properties in vitro, helping to elucidate the mechanistic pathways it influences. As research progresses, CCDC41 is increasingly viewed as a significant player in complex cellular mechanisms, warranting further exploration of its roles in health and disease. Overall, the investigation of CCDC41 and its recombinant protein forms holds promise for advancing our understanding of key biological processes and developing novel therapeutic strategies.












